Introduction
============

Glaucomatous optic neuropathy may be evaluated by direct or indirect ophthalmoscopy of the optic nerve, optic nerve photography, or computerized imaging technologies. Clinical features of glaucomatous optic neuropathy include atrophy of the retinal nerve fiber layer, focal or diffuse narrowing of the neuroretinal rim, optic disc splinter hemorrhage (DH) and parapapillary atrophy (PPA).[@b1-opth-4-971]--[@b3-opth-4-971]

PPA is a form of outer retinal atrophy that abuts the optic disc and can be divided into alpha (α) and beta (β) zones.[@b4-opth-4-971]--[@b6-opth-4-971] Because this atrophy most often lies adjacent to but does not completely surround the nerve, the term parapapillary may be preferable to peripapillary atrophy, though they are used interchangeably in the literature. In βPPA the sclera and large choroidal vessels are visible, as the retinal pigment epithelium (RPE) and most of the photoreceptors are absent.[@b4-opth-4-971],[@b5-opth-4-971] In αPPA, there is an irregular arrangement of RPE cells that can result clinically in both hypo- and hyperpigmentation. The α zone is more peripheral than the β zone when both are present.

Of note, there are no imaging devices to provide automated assessment of DH or PPA, which at the present time are assessed either by patient examination or by photographic interpretation. Interestingly, several studies addressing the topic have found that PPA and DH tend to occur together in eyes and, additionally, tend to occur in the same regions of the eye, leading to the possibility that PPA may be useful as an indicator of increased likelihood of prior, present, or future disc hemorrhage.[@b7-opth-4-971]--[@b12-opth-4-971] Because βPPA is present in 15%--20% of normal eyes, its presence is less specific for glaucoma than DH, which occurs only in 0.6% of healthy eyes.[@b11-opth-4-971],[@b13-opth-4-971] Given that DH is transient, lasting weeks to months, and that PPA is stable and progressive, it may be advantageous to rely on PPA parameters for glaucoma diagnosis and monitoring.[@b8-opth-4-971],[@b12-opth-4-971]

αPPA and βPPA have been evaluated in glaucoma using quantitative analysis of optic nerve photographs (morphometry) typically by manually outlining and measuring the area of PPA using a slide projector, imaging processing software, or with confocal scanning laser ophthalmoscopy.[@b5-opth-4-971]--[@b7-opth-4-971],[@b14-opth-4-971]--[@b20-opth-4-971] Both αPPA and βPPA are larger and occur more frequently in eyes with glaucoma than in normal eyes, though βPPA is more specific for glaucoma.[@b5-opth-4-971],[@b6-opth-4-971],[@b14-opth-4-971],[@b15-opth-4-971] Using these morphometric techniques, PPA has been reported to be helpful in differentiating between normal and glaucomatous eyes.[@b5-opth-4-971],[@b6-opth-4-971],[@b14-opth-4-971],[@b15-opth-4-971],[@b21-opth-4-971]--[@b24-opth-4-971]

While many morphometric investigations of PPA in glaucomatous and normal eyes have reported significant differences between these 2 groups, there is a paucity of information on how clinical evaluation of PPA may guide the clinician in the diagnosis of open-angle glaucoma (OAG). Additionally, it is difficult clinically to estimate quantitative PPA parameters, such as area of PPA, due to its heterogenous shape. Despite this, in a clinical assessment using direct ophthalmoscopy alone, information including the PPA circumferential extent and amount of neuroretinal rim narrowing increased the sensitivity and specificity for detection of glaucomatous visual field loss.[@b1-opth-4-971] However, some previous evaluations of PPA did not consider potential confounding variables such as age or intraocular pressure (IOP) that are typically available to the clinician at the time of diagnosis.[@b1-opth-4-971],[@b5-opth-4-971],[@b6-opth-4-971],[@b14-opth-4-971] In order to determine the clinical utility of PPA evaluation in glaucoma assessment, we developed a clinical PPA grading system and conducted this investigation to determine if clinical PPA assessment could improve the prediction of glaucomatous visual field loss beyond that of standard clinical variables such as age, central corneal thickness (CCT), IOP and vertical cup-to-disc ratio (CDR).

Patients and methods
====================

This retrospective cross-sectional study was approved by the Institutional Review Board at Weill Cornell Medical College and New York Presbyterian Hospital. Patients under 18 years of age or with a history of corneal disease or keratorefractive surgery were excluded, as were patients with visually significant cataract (visual acuity \<20/40), inflammatory eye disease, ocular trauma and non-glaucomatous optic neuropathy, or visual field loss.

Included patients were under evaluation for glaucoma and had documented open angles on examination. All patients had at least one reliable (fixation loss \<33%; false-positive rate \<33%; false-negative rate \<33%) and repeatable 24-2 SITA-standard automatic perimetry with the Humphrey Field Analyzer II (Carl Zeiss Meditec, Dublin, CA, USA). Patients were classified as having OAG if the glaucoma hemifield test (GHT) was borderline or outside normal limits; patients were classified as glaucoma suspects if the GHT was within normal limits. All patients had also undergone optic nerve digital stereophotography of acceptable or excellent quality with a Topcon TRC 50EX Retinal Camera (Topcon Co., Tokyo, Japan) within 18 months of inclusion. Demographic and clinical data including age, sex, self-reported race/ethnicity, CCT, and IOP on the day of examination were obtained by chart review.

One reviewer (NMR) evaluated optic nerve stereophotographs in a masked fashion using stereoscopic viewing lenses ([Figure 1](#f1-opth-4-971){ref-type="fig"}). CDR was recorded. PPA was identified clinically as a parapapillary region of absent (βPPA) or hyper/hypopigmented (αPPA) retinal pigment epithelium. The circumferential extent of total (both α and β) PPA and βPPA were recorded in clock hours; the maximal radial βPPA extent (width) was estimated as a percentage of maximal optic disc dimensions (regardless of absolute optic disc size); the presence or absence of βPPA was assessed at each optic nerve head quadrant; and an ordinal rating (0--3) of total PPA was assigned as follows: grade 0 represented no clinically identifiable αPPA or βPPA; grade 1 represented any level of αPPA only; grade 2 represented any level of αPPA with mild and moderate βPPA; and grade 3 represented βPPA that was extensive either in circumference (12 clock hours) or volume (larger in area than the optic disc itself).

Statistical analyses were performed using Stata 11/IC (StataCorp LP, College Station, TX, USA). Differences in characteristics between patients with normal and abnormal/borderline GHT were assessed using two-sample *t*-tests or the chi-squared test. Differences in quantity of PPA between groups were assessed using generalized estimating equations to control for the inter-eye correlation of individuals; differences in geographic distribution of PPA were tested with the chi-squared test; and the Kruskal--Wallis test was used to test for differences in ordinal PPA rating. Generalized linear models with robust standard errors adjusted for clustering by patient were fit with a logit link function. Odds ratios (ORs) of an abnormal/borderline GHT were estimated as a function of increasing PPA and covariates. The likelihood-ratio test was used to calculate the statistical improvement in model fit when PPA parameters were added to models already containing age, CCT, IOP, and CDR. All statistical tests were 2-sided with a 0.05 level of significance.

Results
=======

Patient characteristics, including PPA parameters, are presented in [Table 1](#t1-opth-4-971){ref-type="table"}. Patients with OAG were significantly older than glaucoma suspects (61.9 versus 55.3 years; *P* \< 0.001), and there was no difference in sex or ethnic/racial distribution between groups (*P* ≥ 0.22). Patients with OAG had significantly greater PPA than glaucoma suspects for all PPA variables measured (*P* ≤ 0.02) except for presence of temporal PPA (*P* = 0.25).

Univariable logistic models were fit to predict the change in odds of OAG as a function of increasing age, CCT, IOP, and CDR ([Table 2](#t2-opth-4-971){ref-type="table"}). Increasing age (OR = 1.4 per 10 years, 95% confidence interval (CI) 1.2, 1.6, *P* \< 0.001) and CDR (OR = 1.3 per 0.1 units, 95% CI 1.2, 1.4, *P* \< 0.001) but not IOP (*P* = 0.71) were significantly associated with greater odds of OAG. Likewise, increasing CCT was significantly associated with decreased odds of an OAG (OR = 0.9 per 10 μm, 95% CI 0.9, 1.0, *P* \< 0.001).

Univariable logistic models were also fit to determine the association of PPA variables with OAG ([Table 3A](#t3-opth-4-971){ref-type="table"}). Again, an increase in each of the PPA parameters (*P* ≤ 0.03), except for presence of temporal βPPA (*P* = 0.30), was found to be significantly associated with an increase in the odds of OAG.

Each PPA variable was then added to a logistic model already containing age, CCT, IOP, and CDR, and the odds of OAG as a function of increasing PPA was determined when adjusting for covariates ([Table 3B](#t3-opth-4-971){ref-type="table"}). With adjustment for age, CCT, IOP, and CDR, the magnitude of association between nasal βPPA and OAG increased compared with the crude association and trended toward statistical significance (OR = 1.6, 95% CI 1.0, 2.7, *P* = 0.06). However, after adjustment for clinical covariates no other PPA variables were statistically significant predictors of the odds of OAG (*P* ≥ 0.10).

Finally, the likelihood-ratio test was used to calculate the change in statistical fit of the model containing age, CCT, IOP, CDR, and a single PPA variable compared with the same model without a PPA variable ([Table 3B](#t3-opth-4-971){ref-type="table"}). Inclusion of the nasal βPPA variable significantly improved model fit (X^2^\[1\] = 4.5, *P* = 0.03). Other PPA variables did not have a statistically significant impact on the fit of the logistic model (*P* ≥ 0.06). While the results of the likelihood-ratio test for total PPA clock hours (X^2^\[1\] = 3.6, *P* = 0.06) and ordinal rating of PPA (X^2^\[3\] = 6.8, *P* = 0.08) trended toward statistical significance, these variables were not significant independent predictors of OAG in their respective multivariable models. The logistic model containing age, CCT, IOP, and CDR correctly predicted the OAG status of 63.2% of eyes. Inclusion of total PPA clock hours in this model improved prediction of OAG status more than other PPA variables, and the percentage of eyes correctly classified increased by 1.2% to a total of 64.4%.

Discussion
==========

Past investigations have demonstrated a strong association between PPA and glaucoma.[@b5-opth-4-971]--[@b7-opth-4-971],[@b14-opth-4-971]--[@b17-opth-4-971],[@b25-opth-4-971]--[@b28-opth-4-971] The purpose of the current investigation was to determine if the clinician could utilize this association in the evaluation of glaucoma patients using visual inspection only. In this investigation, using our clinical grading scale, we replicated trends in the spatial and quantitative distribution of PPA that have been reported among patients with and without glaucoma.[@b6-opth-4-971],[@b14-opth-4-971],[@b15-opth-4-971],[@b29-opth-4-971] While PPA variables were, on their own, significantly predictive of the odds of OAG, this association was greatly attenuated by adjustment for 4 variables that comprise part of a typical glaucoma evaluation: age, CCT, IOP, and CDR. Furthermore, when values for these covariates were already known, modeling of the odds of OAG was not greatly improved by the consideration of PPA variables. This suggests that in clinically evaluating and diagnosing glaucoma there may be little incremental value to assessing PPA.

In the current study, patients with OAG had greater PPA that glaucoma suspects for every measure of PPA that was considered (though the difference was not statistically significant for βPPA of the temporal quadrant). Past studies have shown that βPPA tends to be larger in areas where the neuroretinal rim is focally narrow.[@b14-opth-4-971] Also, as measured with planimetry, the spatial distribution of PPA differs in glaucoma, with PPA being present nasally in 5%--9% of normal patients and 21%--38% of glaucoma patients.[@b6-opth-4-971],[@b14-opth-4-971],[@b15-opth-4-971] A similar trend was confirmed between patients with OAG and glaucoma suspects in the current study. However, the existence of nasal βPPA among 34.7% of OAG patients and only 18.3% of suspects indicates that nasal βPPA is not a sensitive predictor of disease. Past investigations have also demonstrated that PPA is most commonly located temporally, followed by inferotemporally and then superotemporally.[@b29-opth-4-971] In the present study, βPPA was most commonly located temporally among both OAG patients and glaucoma suspects.

In a study by Jonas and colleagues, the investigators sought to determine which features of the optic disc best distinguished normal and glaucomatous patients.[@b20-opth-4-971] The authors found that size of α and β zone PPA, assessed using planimetric techniques, were among the least useful optic disc characteristics for differentiating normal subjects from subjects with either preperimetric or perimetric glaucoma. The variables that consistently offered the greatest diagnostic power in the study by Jonas et al were: CDR, neuroretinal rim area, rim-to-disc area and cup-to-disc area.[@b20-opth-4-971] While these findings largely agree with results from the current study, the current study did not morphometrically investigate optic disc parameters as was done by Jonas et al. Our investigation more specifically addressed the incremental importance of PPA variables, since in nearly all instances the clinician will have knowledge of a patient's age, CCT, IOP, and some measurement of CDR. Like Jonas and colleagues, we determined that PPA variables are not the most important clinical variables for distinguishing glaucomatous and non-glaucomatous patients.

The present study also has the advantage of utilizing a multivariable technique that allows for outcomes to be modeled as a function of multiple variables, as often occurs in the clinical setting. In this study, we considered a model that contained four standard clinical glaucoma variables (age, CCT, IOP, and CDR) with and without the addition of PPA variables. The addition of most PPA variables to this model resulted in little incremental improvement in the modeling of our data. This suggests that the more parsimonious model -- the model without PPA -- more appropriately represents these data.

A growing literature suggests that PPA may be more useful for evaluating progression than for detecting glaucoma.[@b16-opth-4-971]--[@b18-opth-4-971],[@b25-opth-4-971] Studies have shown that PPA increases in size as glaucoma progresses and that it is not specific to the mechanism of glaucoma.[@b16-opth-4-971]--[@b18-opth-4-971],[@b22-opth-4-971],[@b25-opth-4-971] In one report of eyes with progressive cupping, the area of PPA enlarged in 64%, as opposed to 17% of eyes with glaucoma that did not have progressive cupping.[@b16-opth-4-971] Teng and colleagues showed that over a period of 3 years, glaucomatous eyes with β zone PPA were more likely to show evidence of visual field progression and that a greater area of βPPA was predictive of more rapid progression. As in the present study, Teng et al found that CCT was significantly associated with PPA. However, the association between visual field progression and presence of βPPA persisted in a multivariable model controlling for baseline demographic and ocular characeristics.[@b25-opth-4-971] Likewise, Jonas et al found that the area of βPPA was significantly larger among patients with progressive disease and that progression was associated with age, and the area of βPPA and the neuroretinal rim.[@b17-opth-4-971],[@b18-opth-4-971] However, in a study of ocular hypertensives Quigley and colleagues did not find a significant difference in the prevalence of PPA between patients with and without progressive glaucoma.[@b30-opth-4-971]

The current investigation was retrospective in nature so its results cannot be extrapolated to determine risk or future odds of glaucoma. It is possible that patients with normal visual fields (glaucoma suspects) considered in the study might have had pre-perimetric glaucoma, and some of the glaucoma suspects considered might have been referred for evaluation in part based upon the presence of PPA. However, both of the above limitations are commonly encountered in clinical glaucoma management and may actually add to the relevance of this work. This study is less quantitative than past studies that have used planimetric measurement of PPA. However, the clinical grading system that was developed for this study was designed to more closely resemble the sort of evaluation routinely performed in a clinical glaucoma examination. Notwithstanding, by assessing the additional benefit conferred by inclusion of PPA evaluation as part of a standard glaucoma exam, this investigation contributes to the understanding of the association between PPA and OAG.
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![Clinical parapapillary atrophy (PPA) evaluation of 2 patients. **A**) Total PPA clock hours, 12; βPPA clock hours, 5; βPPA as percentage of disc, 60%; βPPA present, temporal; ordinal rating of total PPA, 3. **B**) Total PPA clock hours, 8; βPPA clock hours, 4; βPPA as percentage of disc, 20%; βPPA present, temporal; ordinal rating of total PPA, 2.](opth-4-971f1){#f1-opth-4-971}

###### 

Patient and parapapillary atrophy characteristics

                                             **Glaucoma suspects**   **OAG**        ***P*-value**
  ------------------------------------------ ----------------------- -------------- ---------------
  Number eyes (patients)                     229 (157)               311 (209)      --
  Age (years)                                55.3 (±5.2)             61.9 (±14.2)   \<0.001
  Female (%)                                 64.1                    66.0           0.76
  Race/ethnicity (%)                                                                
  Caucasian                                  34.6                    26.3           0.22
  African-American                           20.5                    30.6           
  Hispanic                                   29.5                    32.1           
  Other race/ethnicity                       15.4                    11.0           
  Clock hours total PPA                      5.1 (±3.5)              6.7 (±3.7)     \<0.001
  Clock hours βPPA                           3.7 (±3.5)              5.2 (±4.3)     \<0.001
  Percent width βPPA                         15.1 (±22.0)            21.0 (±28.2)   0.02
  Percent eyes with βPPA at disc quadrant:                                          
  Temporal (%)                               44.5                    49.5           0.25
  Inferior (%)                               24.9                    34.4           0.02
  Nasal (%)                                  18.3                    34.7           \<0.001
  Superior (%)                               13.5                    24.1           0.002
  Percent eyes with PPA ordinal rating:                                             
  0 (%)                                      7.4                     5.5            \<0.001
  1 (%)                                      54.2                    38.1           
  2 (%)                                      31.9                    39.4           
  3 (%)                                      6.6                     17.1           

**Abbreviations:** OAG, open-angle glaucoma; PPA, parapapillary atrophy.

###### 

Simple logistic models: odds of open-angle glaucoma as a function of common clinical variables

                                                                **OR (95% CI)**   ***P*-value**
  ------------------------------------------------------------- ----------------- ---------------
  Age (per 10 years)                                            1.4 (1.2, 1.6)    \<0.001
  CCT (per 10 μm)                                               0.9 (0.9, 1.0)    0.006
  IOP[a](#tfn2-opth-4-971){ref-type="table-fn"} (per 1 mm Hg)   1.0 (1.0, 1.0)    0.71
  CDR (per 0.1 units)                                           1.3 (1.2, 1.4)    \<0.001

IOP values were with treatment in 59% of patients classified as OAG.

**Abbreviations:** CCT, central corneal thickness; IOP, intraocular pressure; CDR, vertical cup-to-disc ratio.

###### 

Simple and multiple logistic models: odds of open-angle glaucoma as a function of parapapillary atrophy (PPA) variables

  **A. Simple logistic models**                      **B. Adjusted models and model fit**                                     
  -------------------------------------------------- -------------------------------------- --------- ---------------- ------ ------------
  Clock hours total PPA (per 3 hours)                1.4 (1.2, 1.7)                         \<0.001   1.2 (1.0, 1.4)   0.10   0.06 (3.6)
  Clock hours βPPA (per 3 hours)                     1.4 (1.2, 1.6)                         \<0.001   1.1 (0.9, 1.3)   0.20   0.16 (2.0)
  Nasal βPPA                                         1.4 (1.5, 3.7)                         \<0.001   1.6 (1.0, 2.7)   0.06   0.03 (4.5)
  Inferior βPPA                                      1.6 (1.0, 2.4)                         0.03      1.1 (0.7, 1.7)   0.70   0.65 (0.2)
  Temporal βPPA                                      1.2 (0.8, 1.8)                         0.30      0.9 (0.6, 1.3)   0.60   0.49 (0.5)
  Superior βPPA                                      2.0 (1.2, 3.4)                         0.006     1.2 (0.7, 2.1)   0.50   0.51 (0.5)
  Ordinal rating total PPA (reference: rating = 0)                                                                            
  1                                                  1.0 (0.4, 2.1)                         0.90      0.8 (0.4, 1.7)   0.50   0.08 (6.8)
  2                                                  1.7 (0.7, 3.8)                         0.20      1.1 (0.5, 2.6)   0.70   
  3                                                  3.5 (1.4, 9.1)                         0.009     1.6 (0.6, 4.6)   0.30   

Adjusted for: age, CCT, IOP, and CDR.
